Replies to post #273883 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

I don't think so....and I did some homework before I guessed.

Looking at this was interesting, too:
"Chris Ehrlich is a Managing Director and Head of Locust Walk’s Biopharma. He brings significant biotechnology industry and venture capital experience. Since joining Locust Walk in 2013, Chris has been involved with leading multiple transactions for emerging biopharmaceutical companies including TesoRx in their licensing deal with Aspen Pharma, Thar Pharmaceuticals in the acquisition by Grunenthal and Cymabay in their licensing deal with Kowa Pharmaceuticals."

I know it's secondary to most, but none of those 3 transactions appears to have resulted in an approved drug (yet) for the acquirer/licensees.